Delivery Order SPE2DB20D7061-SPE2DB24FSNP4
- Not listed
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $3,931.80 firm fixed-price delivery order is for the supply of XEOMIN 100 unit vials, a pharmaceutical product. The contract has a performance period ending on July 23, 2024 and was awarded on July 1, 2024. AmerisourceBergen, a major pharmaceutical distribution company, holds a large Indefinite Delivery Contract (IDC)...
- This federal contract award, valued at $8,550.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4564795627 units of the pharmaceutical product XEOMIN 50 UNIT VIALS. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,352.44 firm fixed-price delivery order is for the supply of XEOMIN 100 unit vials. The contract has an ultimate completion date of April 14, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,097.00 firm fixed-price delivery order is for the delivery of 200-unit vials of the pharmaceutical product XEOMIN. The contract has a period of performance through March 6, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a $3,669.68 firm fixed price delivery order from the Defense Logistics Agency (DLA) to provide XEOMIN 200 UNIT VIALS. The award has an ultimate completion date of April 2, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation. The $9,710.88 firm-fixed-price contract is for the delivery of 4565063139 XEOMIN 100 unit vials. The ultimate completion date for this award is July 23, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,850.00 firm-fixed-price delivery order is for the supply of XEOMIN 50 unit vials. The contract has an ultimate completion date of October 10, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,704.88 firm fixed-price delivery order is for the supply of 4567346377 XEOMIN 200 UNIT VIALS, with a period of performance through March 14, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,822.36 Firm Fixed Price Delivery Order covers the procurement of 4567589391 XEOMIN 200 UNIT VIALS, with an ultimate completion date of April 4, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a...
- This federal contract award, valued at $1,572.72, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of XEOMIN 100 unit vials, a pharmaceutical product. The contract is a firm fixed price delivery order with a performance period through March 29, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00...
- SPE2DB20D7061Indefinite Delivery Contract
- SPE2DB20D7061-SPE2DB24FSNP4Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $3,931.80 firm fixed price delivery order is for the supply of 100 unit vials of the pharmaceutical product XEOMIN. The contract has a performance period ending on July 2, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract award did not use a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 6/10/24 |